Israel Active

Scientists at Ben-Gurion University are re-designing their Single Actuator Wave-like (SAW) robotic snake to carry a camera and squeeze through the human small intestine.  It could extend and improve the effectiveness of colonoscopy tests.

Top UK Lawyer Mark Lewis (Director of UK Lawyers for Israel) suffers from Multiple Sclerosis, walks with a limp and cannot write with his right hand.  He travels to Israel every six weeks to participate in the MS trial at Jerusalem’s Hadassah Medical Center.

Israel’s Ezer Mizion found a likely DNA match on their database for a bone marrow transplant patient. However, the donor was in the Czech Republic. Using their “Linked to Life” WhatsApp group, volunteers rushed the sample kit from Tel Aviv to Vienna to Prague to Brno and back again in less than 24 hours.

A volunteer with Israel Emergency Medical Service United Hatzalah has developed a smartphone app to quickly locate swimmers in trouble off Haifa’s beaches, and navigate paramedics to that location.

Ben Shetiat’s first call, after completing his 6-months Emergency Medical training course, was an infant having seizures – at Ben’s sister’s house! He arrived in two minutes. After treatment, Ben’s nephew was taken to hospital and was well enough to be discharged later that night.

This could be it.  Teams of Israeli scientists from Tel Aviv University and Sheba and Hadassah Medical centers working together have triggered cell death in tumors. Derivatives of the compound Phenanthridine caused cancer cells to self-destruct in the most resistant and incurable cancers such as pancreatic.  Watch this space!

Ex-Tennessee Titans footballer Tim Shaw has just returned from Jerusalem’s Hadassah Ein Kerem Medical Center following a stem cell transplant to treat ALS (Lou Gehrig’s disease). Cells collected from him in January were purified, replicated and injected back into his spine.

Professor Dror Harats, CEO of VBL Therapeutics on ILTV News described the Phase 2 results of VB-111. The treatment (now in Phase 3 trials) doubles survival time for brain tumor patients and ovarian cancer patients.  It works for most solid tumor cancers.

Professor Asher Bashiri of Israel’s Soroka University Medical Center led the 2017 World Congress on Recurrent Pregnancy Loss, held in Cannes, France. Doctors representing over 50 countries attended.

I reported previously about Israel’s PolyPid slow-release antibiotic bone implants.  PolyPid has just been accepted into the US FDA Qualified Infectious Disease Program - a new FDA status for innovative products in the treatment of bacteria resistant to antibiotics.